Skip to content

Gheuens Sarah

Reporting owner on Forms 3, 4 and 5, CIK 1881190.

Gheuens Sarah reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-10-28.

Issuers

IssuerRoles in the latest filingFilingsLast filed
AGIO · AGIOS PHARMACEUTICALS, INC.CIK 1439222officer (Chief Medical Officer)22026-10-28

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
AGIO · AGIOS PHARMACEUTICALS, INC.Common stock2026-10-26M exercised+7,866$25.0162,511Form 4
AGIO · AGIOS PHARMACEUTICALS, INC.Common stock2026-10-26S sold-7,866$37.6954,645Form 4
AGIO · AGIOS PHARMACEUTICALS, INC.Stock options (right to buy), derivative2026-10-26M exercised-7,866$016,275Form 4
AGIO · AGIOS PHARMACEUTICALS, INC.Common stock2026-10-22M exercised+500$25.0155,145Form 4
AGIO · AGIOS PHARMACEUTICALS, INC.Common stock2026-10-22S sold-500$37.5254,645Form 4
AGIO · AGIOS PHARMACEUTICALS, INC.Stock options (right to buy), derivative2026-10-22M exercised-500$024,141Form 4
AGIO · AGIOS PHARMACEUTICALS, INC.Common stock2026-10-21M exercised+1,489$25.0156,134Form 4
AGIO · AGIOS PHARMACEUTICALS, INC.Common stock2026-10-21S sold-1,489$37.5354,645Form 4
AGIO · AGIOS PHARMACEUTICALS, INC.Stock options (right to buy), derivative2026-10-21M exercised-1,489$024,641Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001439222-26-000124 AGIOS PHARMACEUTICALS, INC.2026-10-28
Form 4 0001439222-26-000122 AGIOS PHARMACEUTICALS, INC.2026-10-23